597 related articles for article (PubMed ID: 33540588)
21. Quorum Sensing in ESKAPE Bugs: A Target for Combating Antimicrobial Resistance and Bacterial Virulence.
Santajit S; Sookrung N; Indrawattana N
Biology (Basel); 2022 Oct; 11(10):. PubMed ID: 36290370
[TBL] [Abstract][Full Text] [Related]
22. Antimicrobial Peptides and Their Therapeutic Potential for Bacterial Skin Infections and Wounds.
Pfalzgraff A; Brandenburg K; Weindl G
Front Pharmacol; 2018; 9():281. PubMed ID: 29643807
[TBL] [Abstract][Full Text] [Related]
23. A Whole-Cell Screen Identifies Small Bioactives That Synergize with Polymyxin and Exhibit Antimicrobial Activities against Multidrug-Resistant Bacteria.
Zimmerman SM; Lafontaine AJ; Herrera CM; Mclean AB; Trent MS
Antimicrob Agents Chemother; 2020 Feb; 64(3):. PubMed ID: 31844003
[TBL] [Abstract][Full Text] [Related]
24. Detection of ESKAPE Bacterial Pathogens at the Point of Care Using Isothermal DNA-Based Assays in a Portable Degas-Actuated Microfluidic Diagnostic Assay Platform.
Renner LD; Zan J; Hu LI; Martinez M; Resto PJ; Siegel AC; Torres C; Hall SB; Slezak TR; Nguyen TH; Weibel DB
Appl Environ Microbiol; 2017 Feb; 83(4):. PubMed ID: 27986722
[TBL] [Abstract][Full Text] [Related]
25. Prevalence and Phenotypic Antimicrobial Resistance among ESKAPE Bacteria and Enterobacterales Strains in Wild Birds.
Russo TP; Minichino A; Gargiulo A; Varriale L; Borrelli L; Pace A; Santaniello A; Pompameo M; Fioretti A; Dipineto L
Antibiotics (Basel); 2022 Dec; 11(12):. PubMed ID: 36551482
[TBL] [Abstract][Full Text] [Related]
26. Antimicrobial Resistance in
Lupo A; Haenni M; Madec JY
Microbiol Spectr; 2018 Jun; 6(3):. PubMed ID: 30101740
[TBL] [Abstract][Full Text] [Related]
27. Differential anti-microbial secondary metabolites in different ESKAPE pathogens explain their adaptation in the hospital setup.
Tiwari V; Meena K; Tiwari M
Infect Genet Evol; 2018 Dec; 66():57-65. PubMed ID: 30227225
[TBL] [Abstract][Full Text] [Related]
28. Bactericidal efficacy of atmospheric pressure non-thermal plasma (APNTP) against the ESKAPE pathogens.
Flynn PB; Higginbotham S; Alshraiedeh NH; Gorman SP; Graham WG; Gilmore BF
Int J Antimicrob Agents; 2015 Jul; 46(1):101-7. PubMed ID: 25963338
[TBL] [Abstract][Full Text] [Related]
29. Prevalence of Infections and Antimicrobial Resistance of ESKAPE Group Bacteria Isolated from Patients Admitted to the Intensive Care Unit of a County Emergency Hospital in Romania.
Bereanu AS; Bereanu R; Mohor C; Vintilă BI; Codru IR; Olteanu C; Sava M
Antibiotics (Basel); 2024 Apr; 13(5):. PubMed ID: 38786129
[TBL] [Abstract][Full Text] [Related]
30. Inactivation Effect of Violet and Blue Light on ESKAPE Pathogens and Closely Related Non-pathogenic Bacterial Species - A Promising Tool Against Antibiotic-Sensitive and Antibiotic-Resistant Microorganisms.
Hoenes K; Bauer R; Meurle T; Spellerberg B; Hessling M
Front Microbiol; 2020; 11():612367. PubMed ID: 33519770
[TBL] [Abstract][Full Text] [Related]
31. [Antiseptic effect of compound lysostaphin disinfectant and its preventive effect on infection of artificial dermis after graft on full-thickness skin defect wound in rats].
Jin J; Zhou H; Cui ZC; Wang L; Luo PF; Ji SZ; Hu XY; Ma B; Wang GY; Zhu SH; Xia ZF
Zhonghua Shao Shang Za Zhi; 2018 Apr; 34(4):225-232. PubMed ID: 29690741
[No Abstract] [Full Text] [Related]
32. Norfloxacin salts of carboxylic acids curtail planktonic and biofilm mode of growth in ESKAPE pathogens.
Lowrence RC; Ramakrishnan A; Sundaramoorthy NS; Shyam A; Mohan V; Subbarao HMV; Ulaganathan V; Raman T; Solomon A; Nagarajan S
J Appl Microbiol; 2018 Feb; 124(2):408-422. PubMed ID: 29178633
[TBL] [Abstract][Full Text] [Related]
33. Antimicrobial, Antibiofilm, and Antioxidant Properties of
Garcia J; Rodrigues F; Castro F; Aires A; Marques G; Saavedra MJ
Front Nutr; 2021; 8():773346. PubMed ID: 35281762
[TBL] [Abstract][Full Text] [Related]
34. CRISPR-Cas, a Revolution in the Treatment and Study of ESKAPE Infections: Pre-Clinical Studies.
González de Aledo M; González-Bardanca M; Blasco L; Pacios O; Bleriot I; Fernández-García L; Fernández-Quejo M; López M; Bou G; Tomás M
Antibiotics (Basel); 2021 Jun; 10(7):. PubMed ID: 34206474
[TBL] [Abstract][Full Text] [Related]
35. Retrospective Analysis on Antimicrobial Resistance Trends and Prevalence of β-lactamases in
Nasser M; Palwe S; Bhargava RN; Feuilloley MGJ; Kharat AS
Microorganisms; 2020 Oct; 8(10):. PubMed ID: 33096921
[TBL] [Abstract][Full Text] [Related]
36. Clonal dispersion of Acinetobacter baumannii in an intensive care unit designed to patients COVID-19.
Durán-Manuel EM; Cruz-Cruz C; Ibáñez-Cervantes G; Bravata-Alcantará JC; Sosa-Hernández O; Delgado-Balbuena L; León-García G; Cortés-Ortíz IA; Cureño-Díaz MA; Castro-Escarpulli G; Vélez-Reséndiz JM; Bello-López JM
J Infect Dev Ctries; 2021 Jan; 15(1):58-68. PubMed ID: 33571146
[TBL] [Abstract][Full Text] [Related]
37. Draft Genome Sequences of Acinetobacter baumannii Isolates from Wounded Military Personnel.
Arivett BA; Ream DC; Fiester SE; Kidane D; Actis LA
Genome Announc; 2016 Aug; 4(4):. PubMed ID: 27563036
[TBL] [Abstract][Full Text] [Related]
38. Celecoxib Enhances the Efficacy of Low-Dose Antibiotic Treatment against Polymicrobial Sepsis in Mice and Clinical Isolates of ESKAPE Pathogens.
Annamanedi M; Varma GYN; Anuradha K; Kalle AM
Front Microbiol; 2017; 8():805. PubMed ID: 28533769
[TBL] [Abstract][Full Text] [Related]
39. Kisameet Clay Exhibits Potent Antibacterial Activity against the ESKAPE Pathogens.
Behroozian S; Svensson SL; Davies J
mBio; 2016 Jan; 7(1):e01842-15. PubMed ID: 26814180
[TBL] [Abstract][Full Text] [Related]
40. Human Salivary Protein Histatin 5 Has Potent Bactericidal Activity against ESKAPE Pathogens.
Du H; Puri S; McCall A; Norris HL; Russo T; Edgerton M
Front Cell Infect Microbiol; 2017; 7():41. PubMed ID: 28261570
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
